Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Precigen Inc (NQ: PGEN )

1.190 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7
Open 1.190
Bid (Size) 1.200 (1)
Ask (Size) 1.370 (36)
Prev. Close 1.190
Today's Range 1.190 - 1.190
52wk Range 0.8050 - 2.900
Shares Outstanding 206,643,428
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
 
Via Benzinga
Hero or Zero? 3 High-Risk Penny Stocks to Make You Rich … or Broke.
Explore the world of high-risk penny stocks, with their potential for significant returns, as we analyze three speculative opportunities. 
Via InvestorPlace

Performance

YTD
-19.59%
-19.59%
1 Month
+0.85%
+0.85%
3 Month
+3.48%
+3.48%
6 Month
-34.62%
-34.62%
1 Year
-11.19%
-11.19%

More News

Read More
Recap: Precigen Q1 Earnings
Via Benzinga
7 High-Potential Penny Stocks in the Biotech Sector
Via InvestorPlace
3 High-Growth Biotech Stocks Poised for Success in 2023
Via InvestorPlace
Precigen Regains Rights To CAR-T Platform For Hematological, Solid Tumor Indications
Via Benzinga
Precigen's Return On Capital Employed Insights
Via Benzinga
Earnings Preview For Precigen
Via Benzinga
3 Healthcare Stocks Insiders Are Buying
Via MarketBeat
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
2 Unmatched Stocks Wall Street Thinks Will Soar 152% or More in the Next 2 Years
Via The Motley Fool
Founders at These 7 Companies Are Loading Up on Their Stock. Should You?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
3 Penny Stocks The Insiders Are Buying
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property
Why Altimmune, Foghorn Therapeutics, and Precigen Shares Crashed This Week
Via The Motley Fool
Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response
Via Benzinga
Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response
Via News Direct
$20 Million Bet On Precigen? Check Out These 4 Penny Stocks Insiders Are Buying
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring, But Not Yet Talking About
Via Benzinga
Nasdaq Falls 50 Points; eHealth Shares Spike Higher
Via Benzinga
Nasdaq Down Over 200 Points; AT&T Posts Upbeat Earnings
Via Benzinga
Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
US Stocks Open Lower; Dow Dips 250 Points
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.